Researchers have used artificial intelligence to screen 80 FDA-approved drugs and reveal which could be used as Alzheimer's treatments.
List view / Grid view
Harvard Medical School (HMS)
A new CRISPR technology has been created to understand mutations based on cytosine to guanine base changes and minimise unintended "off-target" mutations.
Researchers who developed a machine learning algorithm to predict the adverse effects of new drug compounds have released it as an open source tool.